Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
Ets-1 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
Ets-1 a proto-oncogenic transcription factor homologous to the v-ets erythroblastosis virus oncogene. The DNA binding activity of Ets1 is controlled by kinases and transcription factors. It contributes to the regulation of cellular differentiation in hematopoietic cells. Ets1 promotes invasive behavior in endothelial cells, vascular smooth muscle cells and epithelial cancer cells. Regulates the expression of MMP1, MMP3, MMP9 and uPA as well as of VEGF and VEGFR gene expression. Two alternatively spliced isoforms have been described. Note: This description may include information from UniProtKB.
Protein type: Motility/polarity/chemotaxis; Transcription factor; DNA binding protein
Cellular Component: transcription factor complex; nucleus
Molecular Function: protein binding; DNA binding; sequence-specific DNA binding; transcription factor binding; transcription factor activity
Biological Process: transcription from RNA polymerase II promoter; hypothalamus development; transcription, DNA-dependent; positive regulation of transcription, DNA-dependent; positive regulation of erythrocyte differentiation; cell motility involved in cell locomotion; PML body organization and biogenesis; female pregnancy; positive regulation of cell motility; angiogenesis involved in wound healing; response to estradiol stimulus; negative regulation of cell cycle; response to antibiotic; estrous cycle phase; negative regulation of cell proliferation; positive regulation of angiogenesis; response to mechanical stimulus; pituitary gland development; positive regulation of cell proliferation; induction of apoptosis; response to hypoxia; immune response; positive regulation of transcription from RNA polymerase II promoter; positive regulation of cell migration
Reference #:  P14921 (UniProtKB)
Alt. Names/Synonyms: Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1; ets protein; ETS-1; ETS1; EWSR2; FLJ10768; p54; Protein C-ets-1; v-ets avian erythroblastosis virus E2 oncogene homolog 1; v-ets avian erythroblastosis virus E26 oncogene homolog 1; v-ets erythroblastosis virus E26 oncogene homolog 1 (avian)
Gene Symbols: ETS1
Molecular weight: 50,408 Da
Basal Isoelectric point: 5.04  Predict pI for various phosphorylation states
CST Pathways:  B Cell Receptor Signaling  |  MAPK/Erk in Growth and Differentiation  |  Signaling Pathways Activating p38 MAPK
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

Ets-1
Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  Phospho3D  |  DISEASE  |  Source  |  UCSD-Nature  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Sites Implicated In
cell growth, altered: T38‑p
transcription, altered: T38‑p, S251‑p, S257‑p, S282‑p, S285‑p
transcription, induced: T38‑p
activation: T38‑p
inhibition: S251‑p, S257‑p, S282‑p, S285‑p
molecular association, regulation: S251‑p, S257‑p, S282‑p, S285‑p

Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


  MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


        human

 
0 1 K2-a ______MkAAVDLkP
0 1 K8-a MkAAVDLkPTLTIIk
0 1 K15-a kPTLTIIkTEKVDLE
3 0 K15 kPTLTIIKTEKVDLE
0 6 S26-p VDLELFPsPDMECAD
9 5 T38-p CADVPLLtPSSKEMM
1 0 S41 VPLLtPSSKEMMsQA
0 2 S46-p PSSKEMMsQALKATF
0 3 K58-u ATFSGFTkEQQRLGI
0 4 K138-u ILQKEDVkPyQVNGV
0 24 Y140-p QKEDVkPyQVNGVNP
0 25 Y158-p ESRYTSDyFISYGIE
0 1 K200-s SEELLSLkYENDyPs
0 11 Y205-p SLkYENDyPsVILRD
0 1 S207-p kYENDyPsVILRDPL
0 24 Y223-p TDTLQNDyFAIKQEV
2 0 K227 QNDyFAIKQEVVtPD
0 6 T232-p AIKQEVVtPDNMCMG
2 2 S251-p GKLGGQDsFEsIEsy
0 1 S254-p GGQDsFEsIEsyDsC
2 0 S257-p DsFEsIEsyDsCDRL
0 4 Y258-p sFEsIEsyDsCDRLT
0 1 S260-p EsIEsyDsCDRLTQs
0 1 S267-p sCDRLTQsWSsQssF
0 3 S270-p RLTQsWSsQssFNSL
0 4 S272-p TQsWSsQssFNSLQR
0 10 S273-p QsWSsQssFNSLQRV
3 82 S282-p NSLQRVPsyDsFDsE
0 21 Y283-p SLQRVPsyDsFDsED
3 51 S285-p QRVPsyDsFDsEDyP
0 7 S288-p PsyDsFDsEDyPAAL
0 22 Y291-p DsFDsEDyPAALPNH
0 1 K305-a HKPKGTFkDYVRDRA
0 1 K377-u EVARRWGkRkNkPKM
0 1 K379-u ARRWGkRkNkPKMNY
0 1 K381-u RWGkRkNkPKMNYEk
0 1 K388-u kPKMNYEkLSRGLRy
0 1 Y395-p kLSRGLRyYyDKNII
0 1 Y397-p SRGLRyYyDKNIIHK
0 1 Y412-p TAGKRYVyRFVCDLQ
  mouse

 
K2 ______MKAAVDLKP
K8 MKAAVDLKPTLTIIk
K15 KPTLTIIKTEKVDLE
K15-s KPTLTIIkTEKVDLE
S26 VDLELFPSPDMECAD
T38-p CADVPLLtPSsKEMM
S41-p VPLLtPSsKEMMSQA
S46 PSsKEMMSQALKATF
K58-u ATFSGFTkEQQRLGI
K138 ILQKEDVKPYQVNGA
Y140 QKEDVKPYQVNGANP
Y158 ESCYTSDYFISYGIE
K200 SEELLSLKYENDYPS
Y205 SLKYENDYPSVILQD
S207 KYENDYPSVILQDPL
Y223 TDTLQTDYFAIkQEV
K227-s QTDYFAIkQEVLTPD
T232 AIkQEVLTPDNMCLG
S251-p GKLGGQDsFEsVESY
S254-p GGQDsFEsVESYDSC
S257 DsFEsVESYDSCDRL
Y258 sFEsVESYDSCDRLT
S260 EsVESYDSCDRLTQS
S267 SCDRLTQSWSSQSSF
S270 RLTQSWSSQSSFNSL
S272 TQSWSSQSSFNSLQR
S273 QSWSSQSSFNSLQRV
S282-p NSLQRVPsyDsFDYE
Y283-p SLQRVPsyDsFDYED
S285-p QRVPsyDsFDYEDYP
Y288 PsyDsFDYEDYPAAL
Y291 DsFDYEDYPAALPNH
K305 HKPKGTFKDYVRDRA
K377-u EVARRWGkRkNkPKM
K379-u ARRWGkRkNkPKMNY
K381-u RWGkRkNkPKMNYEK
K388 kPKMNYEKLSRGLRY
Y395 KLSRGLRYYYDKNII
Y397 SRGLRYYYDKNIIHK
Y412 TAGKRYVYRFVCDLQ
  rat

 
K2 ______MKAAVDLKP
K8 MKAAVDLKPTLTIIK
K15 KPTLTIIKTEKVDLE
K15 KPTLTIIKTEKVDLE
S26 VDLELFPSPDMECAD
T38 CADVPLLTPSSKEMM
S41 VPLLTPSSKEMMSQA
S46 PSSKEMMSQALKATF
K58 ATFSGFTKEQQRLGI
K138 ILQKEDVKPYQVNGV
Y140 QKEDVKPYQVNGVNP
Y158 ESRYTSDYFISYGIE
K200 SEELLSLKYENDYPS
Y205 SLKYENDYPSVILRD
S207 KYENDYPSVILRDPL
Y223 TDTLQTDYFAIKQEV
K227 QTDYFAIKQEVLTPD
T232 AIKQEVLTPDNMCMG
S251 GKLGGQDSFESIESY
S254 GGQDSFESIESYDSC
S257 DSFESIESYDSCDRL
Y258 SFESIESYDSCDRLT
S260 ESIESYDSCDRLTQS
S267 SCDRLTQSWSSQSSF
S270 RLTQSWSSQSSFNSL
S272 TQSWSSQSSFNSLQR
S273 QSWSSQSSFNSLQRV
S282 NSLQRVPSYDSFDSE
Y283 SLQRVPSYDSFDSED
S285 QRVPSYDSFDSEDYP
S288 PSYDSFDSEDYPAAL
Y291 DSFDSEDYPAALPNH
K305 HKPKGTFKDYVRDRA
K377 EVARRWGKRKNKPKM
K379 ARRWGKRKNKPKMNY
K381 RWGKRKNKPKMNYEK
K388 KPKMNYEKLSRGLRY
Y395 KLSRGLRYYYDKNII
Y397 SRGLRYYYDKNIIHK
Y412 TAGKRYVYRFVCDLQ
  chicken

 
K2 ______MKAAVDLKP
K8 MKAAVDLKPTLTIIK
K15 KPTLTIIKTEKVDID
K15 KPTLTIIKTEKVDID
S26 VDIDLFPSPDMECAD
T38 CADVPLLTPSSKEMM
S41 VPLLTPSSKEMMSQA
S46 PSSKEMMSQALKATF
K58 ATFSGFAKEQQRLGI
K138 ILQKEEAKPYPANGV
Y140 QKEEAKPYPANGVNA
Y158 ESRYTSDYFISYGIE
K200 SEELLSLKYENDYPS
Y205 SLKYENDYPSVILRD
S207 KYENDYPSVILRDPV
Y223 TDSLQTDYFTIKQEV
K227 QTDYFTIKQEVVTPD
T232 TIKQEVVTPDNMCMG
S251-p GKLGGQDsFESIEsY
S254 GGQDsFESIEsYDSC
S257-p DsFESIEsYDSCDRL
Y258 sFESIEsYDSCDRLT
S260 ESIEsYDSCDRLTQS
S267 SCDRLTQSWSSQSSF
S270 RLTQSWSSQSSFQSL
S272 TQSWSSQSSFQSLQR
S273 QSWSSQSSFQSLQRV
S282-p QSLQRVPsYDsFDSE
Y283 SLQRVPsYDsFDSED
S285-p QRVPsYDsFDSEDYP
S288 PsYDsFDSEDYPAAL
Y291 DsFDSEDYPAALPNH
K305 HKPKGTFKDYVRDRA
K377 EVARRWGKRKNKPKM
K379 ARRWGKRKNKPKMNY
K381 RWGKRKNKPKMNYEK
K388 KPKMNYEKLSRGLRY
Y395 KLSRGLRYYYDKNII
Y397 SRGLRYYYDKNIIHK
Y412 TAGKRYVYRFVCDLQ
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.